CTBO — Cantabio Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Cantabio Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2014 March 31st	R2015 March 31st	2016 March 31st	2017 March 31st	2018 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.005	0	0.052	0.032	0.109
Net Total Receivables	0	—	—	—	—
Prepaid Expenses
Total Current Assets	0.005	0	0.052	0.034	0.109
Total Assets	0.005	0	0.052	0.034	0.109
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.007	0.219	0.422	0.887	1.98
Total Long Term Debt
Total Debt
Total Liabilities	0.007	0.219	0.422	0.887	1.98
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.002	-0.218	-0.37	-0.854	-1.87
Total Liabilities & Shareholders' Equity	0.005	0	0.052	0.034	0.109
Total Common Shares Outstanding